NO20035313L - Fremgangsmåte for fremstilling av tialzol PPAR-ligand og polymorfer derav - Google Patents
Fremgangsmåte for fremstilling av tialzol PPAR-ligand og polymorfer deravInfo
- Publication number
- NO20035313L NO20035313L NO20035313A NO20035313A NO20035313L NO 20035313 L NO20035313 L NO 20035313L NO 20035313 A NO20035313 A NO 20035313A NO 20035313 A NO20035313 A NO 20035313A NO 20035313 L NO20035313 L NO 20035313L
- Authority
- NO
- Norway
- Prior art keywords
- polymorphs
- tialzole
- preparation
- ppar ligand
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0113232.3A GB0113232D0 (en) | 2001-05-31 | 2001-05-31 | Chemical process |
| PCT/EP2002/005884 WO2002096893A1 (en) | 2001-05-31 | 2002-05-29 | Process for preparing a thialzole ppar-ligand and polymorphs thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20035313D0 NO20035313D0 (no) | 2003-11-28 |
| NO20035313L true NO20035313L (no) | 2003-12-09 |
Family
ID=9915637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20035313A NO20035313L (no) | 2001-05-31 | 2003-11-28 | Fremgangsmåte for fremstilling av tialzol PPAR-ligand og polymorfer derav |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7244849B2 (cs) |
| EP (1) | EP1395572B1 (cs) |
| JP (1) | JP2004532265A (cs) |
| KR (1) | KR20040007631A (cs) |
| CN (1) | CN1551871A (cs) |
| AT (1) | ATE315556T1 (cs) |
| AU (1) | AU2002317764B2 (cs) |
| BR (1) | BR0209892A (cs) |
| CA (1) | CA2448101A1 (cs) |
| CO (1) | CO5540298A2 (cs) |
| CZ (1) | CZ20033256A3 (cs) |
| DE (1) | DE60208682T2 (cs) |
| ES (1) | ES2256493T3 (cs) |
| GB (1) | GB0113232D0 (cs) |
| HU (1) | HUP0400117A3 (cs) |
| IL (1) | IL158641A0 (cs) |
| MX (1) | MXPA03010943A (cs) |
| NO (1) | NO20035313L (cs) |
| NZ (1) | NZ529486A (cs) |
| PL (1) | PL367114A1 (cs) |
| WO (1) | WO2002096893A1 (cs) |
| ZA (1) | ZA200308570B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
| EP1517882A1 (en) | 2002-06-19 | 2005-03-30 | Eli Lilly And Company | Amide linker peroxisome proliferator activated receptor modulators |
| TW200400816A (en) | 2002-06-26 | 2004-01-16 | Lilly Co Eli | Tricyclic steroid hormone nuclear receptor modulators |
| AU2003261935A1 (en) | 2002-09-06 | 2004-03-29 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
| EP1680131A4 (en) | 2003-08-01 | 2009-05-27 | Janssen Pharmaceutica Nv | SUBSTITUTED INDOLE-O-GLUCOSIDES |
| WO2005097076A2 (en) * | 2004-04-09 | 2005-10-20 | Smithkline Beecham Corporation | Low dose pharmaceutical products |
| WO2007127502A2 (en) * | 2006-01-10 | 2007-11-08 | Smithkline Beecham Corporation | Polymorphic form of { 2-methyl-4- [ 4-methyl-2- ( 4-triflu0r0methylphenyl) thiazol -5- ylmethylthiol phenoxy }-acetic acid |
| US20140112992A1 (en) * | 2011-06-06 | 2014-04-24 | Hetero Research Foundation | Process for febuxostat |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69941777D1 (de) | 1998-03-10 | 2010-01-21 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
| PE20011010A1 (es) * | 1999-12-02 | 2001-10-18 | Glaxo Group Ltd | Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano |
| US7091225B2 (en) * | 2000-12-20 | 2006-08-15 | Smithkline Beecham Corporation | Substituted oxazoles and thiazoles as hPPAR alpha agonists |
| GB0111523D0 (en) * | 2001-05-11 | 2001-07-04 | Glaxo Group Ltd | Chemical compounds |
| GB0113233D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
-
2001
- 2001-05-31 GB GBGB0113232.3A patent/GB0113232D0/en not_active Ceased
-
2002
- 2002-05-29 HU HU0400117A patent/HUP0400117A3/hu unknown
- 2002-05-29 WO PCT/EP2002/005884 patent/WO2002096893A1/en active IP Right Grant
- 2002-05-29 CA CA002448101A patent/CA2448101A1/en not_active Abandoned
- 2002-05-29 AU AU2002317764A patent/AU2002317764B2/en not_active Ceased
- 2002-05-29 US US10/478,260 patent/US7244849B2/en not_active Expired - Fee Related
- 2002-05-29 MX MXPA03010943A patent/MXPA03010943A/es unknown
- 2002-05-29 NZ NZ529486A patent/NZ529486A/en unknown
- 2002-05-29 CN CNA02810885XA patent/CN1551871A/zh active Pending
- 2002-05-29 ES ES02747330T patent/ES2256493T3/es not_active Expired - Lifetime
- 2002-05-29 KR KR10-2003-7015677A patent/KR20040007631A/ko not_active Application Discontinuation
- 2002-05-29 BR BR0209892-0A patent/BR0209892A/pt not_active IP Right Cessation
- 2002-05-29 JP JP2003500072A patent/JP2004532265A/ja active Pending
- 2002-05-29 IL IL15864102A patent/IL158641A0/xx unknown
- 2002-05-29 CZ CZ20033256A patent/CZ20033256A3/cs unknown
- 2002-05-29 PL PL02367114A patent/PL367114A1/xx not_active Application Discontinuation
- 2002-05-29 AT AT02747330T patent/ATE315556T1/de not_active IP Right Cessation
- 2002-05-29 DE DE60208682T patent/DE60208682T2/de not_active Expired - Fee Related
- 2002-05-29 EP EP02747330A patent/EP1395572B1/en not_active Expired - Lifetime
-
2003
- 2003-11-03 ZA ZA200308570A patent/ZA200308570B/en unknown
- 2003-11-26 CO CO03104438A patent/CO5540298A2/es not_active Application Discontinuation
- 2003-11-28 NO NO20035313A patent/NO20035313L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL367114A1 (en) | 2005-02-21 |
| DE60208682D1 (de) | 2006-04-06 |
| WO2002096893A1 (en) | 2002-12-05 |
| NZ529486A (en) | 2005-12-23 |
| KR20040007631A (ko) | 2004-01-24 |
| BR0209892A (pt) | 2004-06-08 |
| IL158641A0 (en) | 2004-05-12 |
| CO5540298A2 (es) | 2005-07-29 |
| GB0113232D0 (en) | 2001-07-25 |
| EP1395572B1 (en) | 2006-01-11 |
| DE60208682T2 (de) | 2006-08-24 |
| US20040242657A1 (en) | 2004-12-02 |
| ATE315556T1 (de) | 2006-02-15 |
| ZA200308570B (en) | 2005-02-03 |
| US7244849B2 (en) | 2007-07-17 |
| ES2256493T3 (es) | 2006-07-16 |
| CZ20033256A3 (en) | 2004-04-14 |
| NO20035313D0 (no) | 2003-11-28 |
| CA2448101A1 (en) | 2002-12-05 |
| EP1395572A1 (en) | 2004-03-10 |
| MXPA03010943A (es) | 2004-02-27 |
| JP2004532265A (ja) | 2004-10-21 |
| HUP0400117A2 (hu) | 2005-03-29 |
| HUP0400117A3 (en) | 2005-09-28 |
| AU2002317764B2 (en) | 2005-01-06 |
| CN1551871A (zh) | 2004-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
| CY1110631T1 (el) | Διαλυτοποιημενα δηλητηρια τοποϊσομερασης | |
| YU59001A (sh) | 16-halogen-epotilon-derivati, postupak za njihovo dobijanje i njihova farmaceutska primena | |
| HK1070063A1 (en) | Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments | |
| GB9822473D0 (en) | Chemical compounds | |
| CY1106743T1 (el) | Μεθοδος παρασκευης θειαμεθοξαμης | |
| WO2005021544A3 (en) | N3-substituted imidazopyridine-derivatives as c-kit inhibitors | |
| YU61103A (sh) | Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola | |
| JO2413B1 (en) | Benzoxazine derivatives and their use | |
| PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
| MXPA03004426A (es) | Proceso quimico y nuevos intermediarios. | |
| BR0209901A (pt) | Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina | |
| MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
| NO20035313L (no) | Fremgangsmåte for fremstilling av tialzol PPAR-ligand og polymorfer derav | |
| WO2007014839A3 (en) | Cathepsin k inhibitors | |
| DE60231426D1 (de) | Solubilisierte topoisomerase-gift-mittel | |
| NO20032401D0 (no) | Fremgangsmåte ved fremstilling av taksanderivater | |
| FI952420A0 (fi) | Glukopyranosidibentsotiofeenit | |
| WO2002072567A3 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| WO2004039776A3 (en) | A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives | |
| SG149005A1 (en) | Process for the preparation of thiazolopyrimidines | |
| EA200100157A3 (ru) | Новые производные арил- или гетероарилхинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции | |
| MXPA04001852A (es) | Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad. | |
| MXPA04001856A (es) | Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos. | |
| MXPA04001846A (es) | Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |